Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Comprehensive Arrhythmia Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 36 | 44 |
|
Arrhythmogenic Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 26 | 18 |
|
Cardiomyopathy and Arrhythmia Panel Mayo Clinic Laboratories Mayo Clinic United States | 73 | 105 |
|
Comprehensive Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 68 | 83 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 23 | 12 |
|
Dilated Cardiomyopathy/LVNC Panel Mayo Clinic Laboratories Mayo Clinic United States | 52 | 63 |
|
Genetic Services Laboratory University of Chicago United States | 116 | 137 |
|
Genetic Services Laboratory University of Chicago United States | 116 | 137 |
|
Arrythmogenic Cardiomyopathy Panel Health in Code Spain | 53 | 17 |
|
Pan Cardiomyopathy Panel (62 Genes) Laboratory for Molecular Medicine Mass General Brigham Personalized Medicine United States | 100 | 61 |
|
Invitae United States | 59 | 16 |
|
LMNA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 11 | 1 |
|
Invitae United States | 59 | 16 |
|
Invitae Hypogonadotropic Hypogonadism Panel Invitae United States | 67 | 46 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 345 | 159 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 110 | 50 |
|
Generalized, Partial and Atypical Lipodystrophy Panel PreventionGenetics, part of Exact Sciences United States | 57 | 29 |
|
Familial Partial Lipodystrophy (FPLD) Panel PreventionGenetics, part of Exact Sciences United States | 29 | 16 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 480 | 254 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.